来自新型DNA编码图书馆的酸选择性PDE3B抑制剂的发现和SAR研究
Ann M Rowley1, Gang Yao2, Logan Andrews3
1GSK, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, United States.
Journal of medicinal chemistry
|January 29, 2024
概括
研究人员使用DNA编码图书馆屏幕识别了新的PDE3B选择性抑制剂. 这些发现对于开发针对代谢障碍和心脏副作用减少的失脂症的治疗方法至关重要.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 二酶3B (PDE3B) 基因与代谢和失脂症表型有关.
- 现有的PDE3抑制剂面临挑战,因为它具有促节律失常的作用,需要PDE3B选择性药物.
- 在PDE3A和PDE3B活性位点之间的高同质性使选择性抑制复杂化.
研究的目的:
- 为了确定PDE3B的强效和选择性抑制剂.
- 为了克服PDE3A和PDE3B之间的活性部位同质性的挑战.
- 发现用于PDE3B向治疗的新型化学物质.
主要方法:
- 使用DNA编码库 (DEL) 屏幕进行高通量选.
- 采用选策略来识别对PDE3B而不是PDE3A具有选择性的化合物.
- 以其抑制活性和选择性来表征已识别的化合物.
主要成果:
- 通过DEL屏幕成功识别了强效和选择性的PDE3B抑制剂.
- 发现了与PDE3B活性部位结合的新型酸化合物.
- 证明了实现PDE3B选择性的可行性,尽管具有高活性位点同质性.
结论:
- 用DNA编码的图书馆选是发现选择性酶抑制剂的有效方法.
- 已识别的酸化合物代表了对PDE3B向药物开发的有希望的线索.
- 实现PDE3B选择性对于减轻与PDE3抑制相关的心血管风险至关重要.
更多相关视频
09:33Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
Published on: March 21, 2018
9.8K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.1K
相关概念视频
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
